Software As A Medical Device Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 3.81 Billion |
| Market Size (2030) | USD 19.58 Billion |
| CAGR (2025 - 2030) | 38.70% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Software As A Medical Device Market Analysis
The Software As A Medical Device Market size is estimated at USD 3.81 billion in 2025, and is expected to reach USD 19.58 billion by 2030, at a CAGR of 38.7% during the forecast period (2025-2030).
- The Software as a Medical Device (SaMD) market is witnessing rapid growth, driven by technological advancements, increasing healthcare demands, and heightened consumer interest. Chronic diseases like diabetes, cardiovascular issues, and respiratory disorders drive the demand for continuous monitoring, remote health management, and personalized care solutions—services that Software as a Medical Device (SaMD) can provide.
- According to the World Health Organization (WHO), 2022 witnessed approximately 20 million new cancer cases globally. Projections indicate this figure could surge to about 35.3 million by 2050, underscoring the escalating challenge of cancer on the global stage.
- The surge in smartphone and wearable device adoption has catalyzed the rise of mobile health applications and SaMDs. These devices seamlessly integrate with SaMDs, enabling real-time monitoring and efficient patient management. With SaMDs, consumers can monitor vital health metrics, such as heart rate and glucose levels, empowering them to take charge of their health proactively.
- SaMD products are increasingly harnessing the power of AI and machine learning for disease diagnosis, medical imaging interpretation, and health outcome predictions, thereby enhancing treatment accuracy and efficacy. Leveraging AI and cloud technology, SaMDs are revolutionizing healthcare access through remote patient monitoring, real-time health data analysis, and telemedicine solutions, significantly curtailing the need for in-person consultations.
- The global aging demographic is amplifying the demand for health management solutions, spotlighting the need for SaMD products to address age-related health challenges. Moreover, regulatory entities like the FDA in the U.S. and the EMA in Europe have rolled out structured guidelines for SaMD approvals, bolstering clarity for manufacturers and instilling confidence in investors. As health authorities increasingly acknowledge the pivotal role of digital health technologies, including SaMDs, in enhancing patient outcomes, there's a noticeable uptick in support and acceptance for these innovations.
- However, obtaining regulatory approval for SaMD products remains a complex and time-consuming process, particularly for high-risk devices. The varying requirements across countries complicate market entry for companies. Furthermore, the necessity for sensitive health data collection in SaMD products raises significant concerns regarding data privacy and security. Lapses in data protection can lead to breaches, undermining consumer trust. Given their dependence on internet connectivity and cloud storage, SaMDs are susceptible to cyberattacks, jeopardizing patient data and posing risks to public health.
- The software as a medical device (SaMD) market faces a complex interplay of challenges and shifts due to war and economic downturns. While wars have heightened the demand for medical solutions in conflict zones, they have also disrupted supply chains, delayed regulations, and heightened cybersecurity risks. On the other hand, economic downturns have curtailed investments in innovation, slashed healthcare spending, and postponed the adoption of new technologies.Such factors are expected to restrict market growth for short period of time.
Software As A Medical Device Market Trends
Smartphones/Tablets Hold Signfiicant Share
- Smartphones and tablets are driving the growth of the software as a medical device (SaMD) market. These devices are now integral to healthcare, facilitating everything from disease diagnosis and management to telemedicine and personalized health monitoring. The increasing smartphone penetration worldwide creates new market opportunities for growth. For instance, according to GSMA Intelligence, in 2023, North America leads in smartphone adoption, boasting an 84 percent penetration rate among total mobile connections. Projections indicate that by 2030, this rate will climb to 89 percent in North America, while regions such as Eurasia and Asia Pacific are set to experience even more significant growth.
- Smartphones and tablets stand out for their portability and user-friendliness. In today's fast-paced world, individuals seek healthcare solutions that seamlessly integrate into their routines. These devices empower users to monitor their health, seek medical advice, and manage chronic conditions anytime, anywhere.
- Applications like remote patient monitoring (RPM), mental health tools, and fitness trackers enable individuals to take charge of their health. From glucose monitoring for diabetics to cognitive behavioral therapy (CBT) apps, these solutions enhance user engagement in healthcare management, leading to better adherence and outcomes. Health-related apps have surged in popularity, with thousands catering to diverse needs, including weight loss, smoking cessation, chronic disease management, and telemedicine.
- With the ubiquity of smartphones and tablets, the health and wellness app market has seen explosive growth. Users increasingly rely on these devices for health tracking, fitness management, nutrition oversight, and symptom monitoring. The surge in health-related apps is evident, with thousands emerging to address needs ranging from weight loss and smoking cessation to chronic disease management and telemedicine.
- Consumer interest is rising in SaMD apps like mobile ECG monitors, sleep trackers, and mental health tools. These solutions not only offer convenience but also empower users to self-manage their health, reducing the need for frequent in-person healthcare visits. This demand is spurring innovation in the SaMD sector, motivating developers to introduce enhanced software products.
- As both consumers and healthcare providers adopt mobile technology, the SaMD market is set for sustained growth and innovation. With the rise of artificial intelligence, cloud computing, and mobile health technologies, the future of healthcare is undeniably digital, with smartphones and tablets at its forefront.
Asia Pacific to Register Major Growth
- The Asia-Pacific region is poised to play a pivotal role in the expansion of the Software as a Medical Device (SaMD) market. Bolstered by an evolving healthcare infrastructure, an intensified emphasis on telemedicine and remote patient monitoring, and an escalating appetite for digital health solutions, APAC nations stand ready to harness the potential of SaMD.
- As chronic ailments such as diabetes, hypertension, and cardiovascular diseases increasingly burden the APAC region, tools for remote monitoring—integrated with mobile health applications and wearables—are facilitating continuous care and enhanced disease management beyond hospital confines. With nations like Japan and China witnessing a swift aging of their demographics, there's a pronounced uptick in healthcare demands, especially concerning chronic condition management and elder care. Solutions under the SaMD umbrella, including remote patient monitoring and apps for chronic disease oversight, present an adept approach to cater to the health needs of this aging populace.
- The Asia-Pacific has emerged as a global nexus for HealthTech startups, many channeling their efforts into pioneering SaMD innovations. The digital health landscape is witnessing a surge in investments, with venture capital increasingly backing health applications, wearables, AI-driven diagnostics, and telemedicine solutions.
- Both China and India are nurturing a burgeoning ecosystem of local health startups, adeptly serving both their home turf and international clientele. These enterprises are tapping into the region's technological landscape to craft state-of-the-art solutions tailored to the distinct demands of the APAC populace. Recognizing the significance of digital health, APAC governments are rolling out supportive policies and regulatory frameworks to bolster the SaMD market's growth. For instance, in FY 2024, India's health sector was allocated a substantial budget of approximately 985 billion Indian rupees, marking a consistent uptick in health budget allocations since FY 2018.
- As healthcare systems in nations like India and China grapple with escalating care costs, SaMD solutions emerge as a financially savvy alternative. By facilitating remote monitoring and curtailing hospital visits, these solutions promise enhanced health outcomes while optimizing resource use. With the dual forces of rising smartphone adoption and the proliferation of AI-centric healthcare innovations, the region is charting its course to ascend as the global vanguard in digital health. The collective embrace of SaMDbby governments, healthcare entities, and consumers alike underscores a shared vision: an enhanced healthcare delivery system, optimized costs, and superior health outcomes, heralding a more interconnected and healthier tomorrow.
Software As A Medical Device Industry Overview
The software as a medical device market is highly fragmented, with global and local conglomerates and specialized players operating across various segments. while several large multinational companies dominate specific high-value segments, numerous regional and niche players contribute to the overall competition, making the market highly diverse. this fragmentation is driven by the demand for software as a medical device across a wide range of end-user verticals, allowing both large and small companies to coexist and thrive in the market.
Leading companies in the software as a medical device market include MindMaze, Siemens Healthcare, Biofourmis, Digital Diagnostics Inc., Silicon & Software Systems Ltd., BrightInsight, Arterys, Medtronic Plc, and iSchemaView Inc.. These companies have established strong brand recognition and extensive global operations, enabling them to command significant market share. Their strengths lie in innovation, broad product portfolios, and strong distribution networks. These leaders often engage in strategic acquisitions and partnerships to maintain their competitive edge and expand their market reach.
Numerous companies are channeling investments into artificial intelligence (AI) and machine learning (ML) to craft advanced diagnostic tools, enhance predictive analytics, and tailor health recommendations. These companies are also prioritizing the development of Software as a Medical Device (SaMD) solutions that cater to individualized healthcare needs. With the rising acceptance of digital health solutions, a growing number of SaMD firms are turning to direct-to-consumer (DTC) marketing strategies, aiming for more effective engagement with end users.
Software As A Medical Device Market Leaders
-
Siemens Healthcare
-
Silicon & Software Systems Ltd.
-
Digital Diagnostics Inc.
-
MindMaze
-
iSchemaView Inc.
- *Disclaimer: Major Players sorted in no particular order
Software As A Medical Device Market News
- August 2024: AlgoDx, boasts EU and UK-approved machine learning software for sepsis prediction that's already in commercial use. The company has secured the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its sepsis detection software, powered by its proprietary algorithm, NAVOY CDS. This achievement signifies a significant leap for AlgoDx as it ventures into the U.S. market. NAVOY CDS is classified as software as a medical device (SaMD). It's crafted to assist clinicians in pinpointing sepsis in hospitalized patients, even in the Emergency Department. By tapping into routinely gathered vital parameters, NAVOY CDS scrutinizes patient data, offering early alerts for sepsis. This proactive approach, targeting a potentially life-threatening condition, empowers healthcare professionals to act swiftly and decisively.
- February 2024: Bittium Corporation has broadened its ECG analysis software portfolio by partnering with Polish Medicalgorithmics S.A., a provider of AI-driven cardiac diagnostic software. This collaboration allows Bittium to deliver a more holistic solution for arrhythmia diagnosis to its clientele. Aligning with this strategy, Bittium is concentrating on enhancing its current products and consistently elevating their quality.
Software As A Medical Device Industry Segmentation
Software as a Medical Device (SaMD) refers to software intended for medical purposes, either independently or in conjunction with other medical devices, yet not integrated into a hardware device. SaMD is crafted to execute distinct medical functions like diagnosing, monitoring, preventing, or treating diseases and is specifically designed for the healthcare environment.
The study tracks the revenue accrued through the sale of software as a medical device by various players across the globe. It also tracks the key market parameters, underlying growth influencers, and major vendors operating in the industry, which supports the market estimations and growth rates over the forecast period. The study further analyses the overall impact of COVID-19 aftereffects and other macroeconomic factors on the market. The report’s scope encompasses market sizing and forecasts for the various market segments.
The software as a medical device market is segmented by device type (laptops/PCs, smartphones/tablets, and wearable devices), deployment (cloud-based and on-premise), and geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America). The market sizes and forecasts regarding value (USD) for all the above segments are provided.
| By Device Type | Laptops/PCs |
| Smartphones/Tablets | |
| Wearable Devices | |
| By Deployment | Cloud-based |
| On-Premise | |
| By Geography*** | North America |
| Europe | |
| Asia | |
| Australia and New Zealand | |
| Middle East and Africa | |
| Latin America |
Software As A Medical Device Market Research FAQs
How big is the Software As A Medical Device Market?
The Software As A Medical Device Market size is expected to reach USD 3.81 billion in 2025 and grow at a CAGR of 38.70% to reach USD 19.58 billion by 2030.
What is the current Software As A Medical Device Market size?
In 2025, the Software As A Medical Device Market size is expected to reach USD 3.81 billion.
Who are the key players in Software As A Medical Device Market?
Siemens Healthcare, Silicon & Software Systems Ltd., Digital Diagnostics Inc., MindMaze and iSchemaView Inc. are the major companies operating in the Software As A Medical Device Market.
Which is the fastest growing region in Software As A Medical Device Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Software As A Medical Device Market?
In 2025, the North America accounts for the largest market share in Software As A Medical Device Market.
What years does this Software As A Medical Device Market cover, and what was the market size in 2024?
In 2024, the Software As A Medical Device Market size was estimated at USD 2.34 billion. The report covers the Software As A Medical Device Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Software As A Medical Device Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Software As A Medical Device Industry Report
Statistics for the 2025 Software As A Medical Device market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Software As A Medical Device analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
